By CFS Central:
On the patient forum Phoenix Rising, there’s been discussion recently about mutations in the Vitamin D Receptor (VDR) gene predicting patient response to the experimental drug GcMAF. GcMAF (pronounced G C “MAF”) is believed to work on HIV, cancer and, now, ME/CFS.
These diseases turn off white cells called macrophages whose job is to ingest pathogens, and GcMAF presumably ... Read more>>
No comments:
Post a Comment